Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update
Aug 10, 2017 20:01 pm UTC| Business
John Walker appointed permanent CEO at Zosano FREMONT, Calif., Aug. 10, 2017 -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage biopharmaceutical company focused on providing systemic administration of...
Microbot Medical Inc. to Report Second Quarter Results on August 14, 2017
Aug 10, 2017 20:01 pm UTC| Business
HINGHAM, Mass., Aug. 10, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, will release second...
The Trade Desk Reports Second Quarter Financial Results
Aug 10, 2017 20:01 pm UTC| Business
LOS ANGELES, Aug. 10, 2017 -- The Trade Desk, Inc. (NASDAQ:TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its second quarter ended June 30, 2017. ...
SWK Holdings Corporation Announces 2017 Second Quarter Financial Results
Aug 10, 2017 20:01 pm UTC| Business
Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016. Net income attributable to SWK Shareholders of $3.4 million, or $0.26 per share, and...
Navigators Promotes Pat Milner to President of NavTech
Aug 10, 2017 20:01 pm UTC| Business
STAMFORD, Conn., Aug. 10, 2017 -- The Navigators Group, Inc. (NASDAQ:NAVG) today announced the promotion of Patrick J. Milner to President of NavTech, the company’s global business unit underwriting upstream and...
Ideal Power Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:01 pm UTC| Business
AUSTIN, Texas, Aug. 10, 2017 -- Ideal Power Inc. (NASDAQ:IPWR), an innovative power conversion technology company, reported results for the three and six months ended June 30, 2017. Key Second Quarter 2017 and...
CareDx Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:01 pm UTC| Business
BRISBANE, Calif., Aug. 10, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...